OXB.L Stock Analysis
OX
Uncovered
Oxford Biomedica PLC is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Oxford Biomedica Plc is a biopharmaceutical company, which engages in the research and development of gene and cell therapy. The company is headquartered in Oxford, Oxfordshire and currently employs 959 full-time employees. The firm and its subsidiaries are engaged in viral vector delivery systems, including those based on lentivirus, adeno-associated virus (AAV) and adenovirus. The company provides solutions to cell and gene therapy biotechnology and biopharma companies for their process development, analytical development and manufacturing needs. The firm has built a LentiVector platform, which is focused on a lentiviral vector delivery system. The firm is engaged in working on programs from the pre-clinical to commercial stages across a range of therapeutic areas with global partners. The firm has manufacturing, laboratory and office space across six facilities in Oxford, United Kingdom. The Company’s subsidiary, Oxford Biomedica Solutions LLC, has an AAV manufacturing facility near Boston, Massachusetts, the United States.